Snook C P, Sigvaldason K, Kristinsson J
Department of Emergency Medicine, Iceland Poison Information Centre, Reykjavik Hospital.
J Toxicol Clin Toxicol. 2000;38(6):661-5. doi: 10.1081/clt-100102018.
A case of combined, massive overdose of both atenolol and diltiazem in an adult male is reported. Cardiac arrest ensued which was responsive to cardiopulmonary resuscitation. Bradycardia, hypotension, and oliguria followed which were resistant to intravenous pacing and multiple pharmacologic interventions, including intravenous fluids, calcium, dopamine, dobutamine, epinephrine, prenalterol, and glucagon. Adequate mean arterial pressure and urine output were restored only after addition of phenylephrine to therapy with multiple agents and transvenous pacing. The patient survived until discharge after a hospital course complicated by nontransmural myocardial infarct on hospital day 4 and pneumonia. Laboratory testing subsequently revealed high serum levels of both atenolol and diltiazem. The atenolol level of 35 microg/mL in this patient is the highest reported associated with survival.
This case illustrates severe cardiovascular toxicity after overdose of both atenolol and diltiazem. Oliguria, which has previously been reported in severe atenolol overdose, was successfully treated without hemodialysis by the addition of phenylephrine to aggressive therapy with pacing, inotropic, and pressor support.
本文报告了一名成年男性同时过量服用大量阿替洛尔和地尔硫䓬的病例。随后发生心脏骤停,经心肺复苏后有反应。接着出现心动过缓、低血压和少尿,对静脉起搏及多种药物干预措施(包括静脉补液、钙剂、多巴胺、多巴酚丁胺、肾上腺素、普瑞特罗和胰高血糖素)均无反应。仅在多种药物治疗中加用去氧肾上腺素并进行经静脉起搏后,才恢复了足够的平均动脉压和尿量。患者在住院期间出现非透壁性心肌梗死(于住院第4天)及肺炎等并发症,最终存活至出院。实验室检查随后显示血清阿替洛尔和地尔硫䓬水平均升高。该患者阿替洛尔水平为35微克/毫升,是报告的与存活相关的最高水平。
本病例说明了阿替洛尔和地尔硫䓬过量后的严重心血管毒性。先前报道严重阿替洛尔过量时出现的少尿,通过在积极的起搏、强心和升压支持治疗中加用去氧肾上腺素,未进行血液透析即成功治愈。